Skip to content
Screener

Vanda Pharmaceuticals VNDA Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$56.3MMiss by $3.0M
EPS-$0.38Miss by $0.07
Revenue estimate$59.3M
EPS estimate-$0.31

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$69.3M
EPS estimate-$0.72

FAQ

When did Vanda Pharmaceuticals report Q3 2025 earnings?
Vanda Pharmaceuticals (VNDA) reported Q3 2025 earnings on October 29, 2025 after market close.
What were Vanda Pharmaceuticals's Q3 2025 revenue and EPS?
Vanda Pharmaceuticals reported revenue of $56.3M and eps of $-0.38 for Q3 2025.
Did Vanda Pharmaceuticals beat estimates in Q3 2025?
Revenue missed the consensus estimate of $59.3M by $3.0M. EPS missed the consensus estimate of $-0.31 by $0.07.
How did Vanda Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.1% from $47.7M a year earlier and eps declined 322.2% from $-0.09.
Where can I find Vanda Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-047112) and the 10-Q periodic report (0001628280-25-047317) directly on SEC EDGAR. The filing index links above go to sec.gov.